Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

Phreesia stock opened at $27.12 on Thursday. The company’s 50-day moving average price is $23.18 and its 200-day moving average price is $22.71. The company has a quick ratio of 1.77, a current ...

In a report released today, Jailendra Singh from Truist Financial assigned a Buy rating to Phreesia (PHR – Research Report). The company’s ...

5 analysts have shared their evaluations of Phreesia PHR during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their recent ratings ...

Phreesia, Inc. (NYSE:PHR), a leading healthcare technology company specializing in patient intake management and workflow optimization, has been garnering attention from analysts and investors alike.

$30,000 of PHREESIA INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Lobbying related to patient reported quality ...